Cargando…

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review

Hallucinogen-persisting perception disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects. HPPD was associated with a broader range of LSD (lysergic acid diethylamide)-like substances, cannabis, methylenedioxymethampheta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsolini, Laura, Papanti, Gabriele Duccio, De Berardis, Domenico, Guirguis, Amira, Corkery, John Martin, Schifano, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701998/ https://www.ncbi.nlm.nih.gov/pubmed/29209235 http://dx.doi.org/10.3389/fpsyt.2017.00240

Ejemplares similares

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
por: Orsolini, Laura, et al.
Publicado: (2020)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction
por: Chiappini, Stefania, et al.
Publicado: (2020)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

The Psychonauts’ World of Cognitive Enhancers
por: Napoletano, Flavia, et al.
Publicado: (2020)

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
por: Orsolini, Laura, et al.
Publicado: (2017)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2019)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
por: Schifano, Fabrizio, et al.
Publicado: (2021)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
por: Schifano, Fabrizio, et al.
Publicado: (2019)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
por: Chiappini, Stefania, et al.
Publicado: (2021)

Modulation of Social Cognition via Hallucinogens and “Entactogens”
por: Preller, Katrin H., et al.
Publicado: (2019)

Editorial: “No Words for Feelings, Yet!” Exploring Alexithymia, Disorder of Affect Regulation, and the “Mind-Body” Connection
por: De Berardis, Domenico, et al.
Publicado: (2020)

New Challenges for Translational Psychopharmacology
por: Bourin, Michel
Publicado: (2010)

Psychological and Psychopharmacological Interventions in Psychocardiology
por: Kahl, Kai G., et al.
Publicado: (2022)

Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences
por: Ballentine, Galen, et al.
Publicado: (2022)

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
por: Arillotta, Davide, et al.
Publicado: (2021)

Alprazolam-related deaths in Scotland, 2004–2020
por: Corkery, John Martin, et al.
Publicado: (2022)

Editorial: Women in Psychiatry 2021: Psychopharmacology
por: Jan, Reem Kais, et al.
Publicado: (2022)

Editorial: Women in psychiatry 2022: Psychopharmacology
por: Camarini, Rosana, et al.
Publicado: (2023)

Hallucinogen-persisting Perception Disorder in a 21-year-old Man
por: Kurtom, Muhannad, et al.
Publicado: (2019)

Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
por: Müller, Felix, et al.
Publicado: (2020)

Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report
por: Haslacher, David, et al.
Publicado: (2022)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
por: Chiappini, Stefania, et al.
Publicado: (2022)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
por: Langlitz, Nicolas, et al.
Publicado: (2021)

Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia
por: Mayer, Juliane, et al.
Publicado: (2022)

‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse
por: Orsolini, Laura, et al.
Publicado: (2021)

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
por: Catalani, Valeria, et al.
Publicado: (2021)

Editorial: Real-World Evidence of Pediatric Exposure to Psychopharmacologic Medications
por: Zito, Julie M., et al.
Publicado: (2022)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
por: Chiappini, Stefania, et al.
Publicado: (2021)

Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
por: Girala, N.
Publicado: (2022)

Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients
por: Martinotti, Giovanni, et al.
Publicado: (2020)

Grand Challenge in Psychopharmacology: Setting Priorities to Shape a Bright Future
por: Ciccocioppo, Roberto
Publicado: (2017)

Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
por: Vento, Alessandro E., et al.
Publicado: (2021)

Overcoming Fear of Flying: A Combined Approach of Psychopharmacology and Gradual Exposure Therapy
por: Abuso, Athena Beth V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vurdekp4kbu6jpqj4i4rvnpqjc